Argov Z - Search Results

1

Miller FW, Rider LG, Plotz PH, Rutkove SB, Pestronk A, Wortmann RL, Lundberg IE, Argov Z, Isenberg DA, Lacomis D, Oddis CV. Miller FW, et al. Among authors: argov z. Neurology. 2004 Jul 27;63(2):402; author reply 403. Neurology. 2004. PMID: 15277657 No abstract available.

2

Various classes of mutations in patients with phosphofructokinase deficiency (Tarui's disease).

Raben N, Sherman JB, Adams E, Nakajima H, Argov Z, Plotz P. Raben N, et al. Among authors: argov z. Muscle Nerve Suppl. 1995;3:S35-8. doi: 10.1002/mus.880181409. Muscle Nerve Suppl. 1995. PMID: 7603525

3

Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII--and their population frequency.

Sherman JB, Raben N, Nicastri C, Argov Z, Nakajima H, Adams EM, Eng CM, Cowan TM, Plotz PH. Sherman JB, et al. Among authors: argov z. Am J Hum Genet. 1994 Aug;55(2):305-13. Am J Hum Genet. 1994. PMID: 8037209 Free PMC article.

4

Characterization of Strength and Function in Ambulatory Adults With GNE Myopathy.

Argov Z, Bronstein F, Esposito A, Feinsod-Meiri Y, Florence JM, Fowler E, Greenberg MB, Malkus EC, Rebibo O, Siener CS, Caraco Y, Kolodny EH, Lau HA, Pestronk A, Shieh P, Skrinar AM, Mayhew JE. Argov Z, et al. J Clin Neuromuscul Dis. 2017 Sep;19(1):19-26. doi: 10.1097/CND.0000000000000181. J Clin Neuromuscul Dis. 2017. PMID: 28827485 Free PMC article.

5

Clinical differentiation between primary lateral sclerosis and upper motor neuron predominant amyotrophic lateral sclerosis.

Gotkine M, Argov Z. Gotkine M, et al. Among authors: argov z. Arch Neurol. 2007 Oct;64(10):1545; author reply 1545. doi: 10.1001/archneur.64.10.1545-a. Arch Neurol. 2007. PMID: 17923644 No abstract available.

6

Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study.

Argov Z, Caraco Y, Lau H, Pestronk A, Shieh PB, Skrinar A, Koutsoukos T, Ahmed R, Martinisi J, Kakkis E. Argov Z, et al. J Neuromuscul Dis. 2016 Mar 3;3(1):49-66. doi: 10.3233/JND-159900. J Neuromuscul Dis. 2016. PMID: 27854209 Free PMC article. Clinical Trial.

7

Inclusion body myositis: atypical clinical presentations.

Schlesinger I, Soffer D, Lossos A, Meiner Z, Argov Z. Schlesinger I, et al. Among authors: argov z. Eur Neurol. 1996;36(2):89-93. doi: 10.1159/000117215. Eur Neurol. 1996. PMID: 8654492

8

Late-onset muscular weakness in phosphofructokinase deficiency due to exon 5/intron 5 junction point mutation: a unique disorder or the natural course of this glycolytic disorder?

Argov Z, Barash V, Soffer D, Sherman J, Raben N. Argov Z, et al. Neurology. 1994 Jun;44(6):1097-100. doi: 10.1212/wnl.44.6.1097. Neurology. 1994. PMID: 8208408

9

Metabolic myopathy in canine muscle-type phosphofructokinase deficiency.

Giger U, Argov Z, Schnall M, Bank WJ, Chance B. Giger U, et al. Among authors: argov z. Muscle Nerve. 1988 Dec;11(12):1260-5. doi: 10.1002/mus.880111210. Muscle Nerve. 1988. PMID: 2976895

10

Impairment of muscle mitochondrial oxidative metabolism in McArdles's disease.

De Stefano N, Argov Z, Matthews PM, Karpati G, Arnold DL. De Stefano N, et al. Among authors: argov z. Muscle Nerve. 1996 Jun;19(6):764-9. doi: 10.1002/(SICI)1097-4598(199606)19:6<764::AID-MUS12>3.0.CO;2-L. Muscle Nerve. 1996. PMID: 8609928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters